Skip to main content
Premium Trial:

Request an Annual Quote

LGC to Distribute Diagenode DNA Fragmentation Instruments

NEW YORK (GenomeWeb) – LGC's genomics division has signed a distribution agreement with Diagenode to distribute its sonication systems for DNA fragmentation.

The agreement covers the clinical and agricultural biotechnology markets in Europe, the Middle East, Africa, South America, and Canada, and the agbio market in the US. London-based LGC, an international provider of measurement products and services, said the deal is part of its expansion into the next-generation sequencing market.

"Combining our leading DNA shearing platforms with LGC's solutions, allows us to strengthen our presence in key market sectors and contribute to the development of NGS applications in the agricultural biotech and human healthcare sectors," Philippe Cronet, business unit manager of epigenetics at Diagenode, said in a statement.

Brian Kim, president and managing director of LGC's genomics division, added that Diagenode's sonication systems are "key additions to our product portfolio and allow us to provide our customers, globally, a critical step within the NGS workflow."